MedTrace Logo

Development and Validation of an Early Prediction Model for Severe Mycoplasma Pneumoniae Pneumonia in Children

NCT07333833 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 964

Last updated 2026-01-12

No results posted yet for this study

Summary

Pneumonia is a major threat to the health of children. Mycoplasma pneumoniae infection is a core cause of pediatric pneumonia, and the incidence of severe mycoplasma pneumoniae pneumonia (SMPP) has increased in recent years. SMPP leads to a range of extrapulmonary symptoms, including myocardial and liver injury, which may be life-threatening. Therefore, there is an urgent need to establish an early warning model for SMPP to improve the prognosis of pediatric pneumonia. This observational study aims to establish a early prediction model of SMPP. Development cohorts are enrolled from Beijing Friendship Hospital between 2018-1-1 to 2024-5-31, and validation cohorts are enrolled between 2024-6-1 to 2025-6-30.

Conditions

  • Mycoplasma Pneumoniae Pneumonia

Interventions

OTHER

medical history taking, blood test, pulmonary ultrasound

medical history taking, blood test, pulmonary ultrasound are used for MPP and SMPP diagnosis

Sponsors & Collaborators

  • Beijing Friendship Hospital

    lead OTHER

Eligibility

Min Age
1 Month
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2025-06-30
Completion
2025-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07333833 on ClinicalTrials.gov